New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research finds removing ovaries at benign hysterectomy carries health risks

Research finds removing ovaries at benign hysterectomy carries health risks

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainAn emulated target trial of more than 140,000 women in Denmark found that removing the ovaries at benign hysterectomy was associa
OB & GYN May 27,2024
Research finds removing ovaries at benign hysterectomy carries health risks

Research finds removing ovaries at benign hysterectomy carries health risks

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainAn emulated target trial of more than 140,000 women in Denmark found that removing the ovaries at benign hysterectomy was associa
OB & GYN May 27,2024
Study uncovers pregnant women's fears during the COVID-19 pandemic

Study uncovers pregnant women's fears during the COVID-19 pandemic

by WileyCredit: Pixabay/CC0 Public DomainIn a survey-based study published inNursing Open, fear was present in 95.2% of pregnant women during the first months of the COVID-19 pandemic. Fear
OB & GYN May 27,2024
Study uncovers pregnant women's fears during the COVID-19 pandemic

Study uncovers pregnant women's fears during the COVID-19 pandemic

by WileyCredit: Pixabay/CC0 Public DomainIn a survey-based study published inNursing Open, fear was present in 95.2% of pregnant women during the first months of the COVID-19 pandemic. Fear
OB & GYN May 27,2024
Drinking alcohol even at conception damages placenta development: study

Drinking alcohol even at conception damages placenta development: study

by The Company of BiologistsCredit: CC0 Public DomainAlcohol consumption during pregnancy has been linked to poor growth of the placenta, causing conditions such as fetal growth restriction and l
OB & GYN May 27,2024
Drinking alcohol even at conception damages placenta development: study

Drinking alcohol even at conception damages placenta development: study

by The Company of BiologistsCredit: CC0 Public DomainAlcohol consumption during pregnancy has been linked to poor growth of the placenta, causing conditions such as fetal growth restriction and l
OB & GYN May 27,2024
Study examines effects of taking ondansetron during first trimester of pregnancy

Study examines effects of taking ondansetron during first trimester of pregnancy

by Brigham and Women's HospitalCredit: CC0 Public DomainOndansetron (Zofran) is commonly and increasingly prescribed during pregnancy to relieve nausea. In 2014, an estimated 22 percent of pr
OB & GYN May 27,2024
Study examines effects of taking ondansetron during first trimester of pregnancy

Study examines effects of taking ondansetron during first trimester of pregnancy

by Brigham and Women's HospitalCredit: CC0 Public DomainOndansetron (Zofran) is commonly and increasingly prescribed during pregnancy to relieve nausea. In 2014, an estimated 22 percent of pr
OB & GYN May 27,2024
Study finds tuberculosis treatment during pregnancy is safe for mom and baby

Study finds tuberculosis treatment during pregnancy is safe for mom and baby

by Curtin UniversityCredit: Unsplash/CC0 Public DomainSeven out of 10 pregnant women were cured of their multidrug-resistant tuberculosis and delivered healthy babies after taking a medication th
OB & GYN May 27,2024
Study finds tuberculosis treatment during pregnancy is safe for mom and baby

Study finds tuberculosis treatment during pregnancy is safe for mom and baby

by Curtin UniversityCredit: Unsplash/CC0 Public DomainSeven out of 10 pregnant women were cured of their multidrug-resistant tuberculosis and delivered healthy babies after taking a medication th
OB & GYN May 27,2024
Team identifies genes that increase risk for triple-negative breast cancer

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi
Oncology May 27,2024
Team identifies genes that increase risk for triple-negative breast cancer

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi
Oncology May 27,2024
Research team identifies a potential strategy in fight against brain cancer

Research team identifies a potential strategy in fight against brain cancer

by Virginia TechA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists with the Virginia Tech Carilion Research I
Oncology May 27,2024
Research team identifies a potential strategy in fight against brain cancer

Research team identifies a potential strategy in fight against brain cancer

by Virginia TechA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists with the Virginia Tech Carilion Research I
Oncology May 27,2024
Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj
Oncology May 27,2024
Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj
Oncology May 27,2024
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Oncology May 27,2024
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Oncology May 27,2024
Researches novel triple-negative breast cancer treatments

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a
Oncology May 27,2024
Researches novel triple-negative breast cancer treatments

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a
Oncology May 27,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com